How long does Wegovy stay in your system — and why does it matter?

You've just taken your last dose, here's what happens next

Picture the situation: your final injection was last Tuesday. The pen goes back in the sharps bin, and you wonder how long the medicine stays at work. Semaglutide's half-life of roughly seven days means that one week after that last dose, about half the drug remains in circulation. Another week on, half of that. By the end of five weeks, concentrations have fallen to well below 5% of peak, low enough that most people notice a return of appetite and a loosening of the gastric-emptying effect that slows digestion. That is the practical clearance window: not a sudden switch but a gradual fade over four to five weeks.

This matters for anyone stopping Wegovy deliberately, whether because a prescriber has advised a break, because they are switching treatment, or because supply has been interrupted. The timeline from last injection to out-of-system is the same regardless of reason: slow and predictable. What usually returns first is hunger between meals, then appetite at mealtime. Most people do not feel an abrupt change on day one; week two to three is more commonly when it becomes noticeable. If you want a closer look at how long Wegovy stays in your system and what drives that window, the factors behind the half-life calculation are worth understanding before you stop. Understanding that rhythm helps you plan rather than panic.

The NHS medicines page on semaglutide notes that side effects, including nausea and changes to digestion, are most likely around dose changes, and the same logic applies in reverse when concentrations fall. For anyone who wants to follow the numbers more precisely, our guide on how long before semaglutide is out of your system walks through the week-by-week picture in detail. If you are planning a procedure or pregnancy after stopping, your prescriber will advise on the appropriate gap; that conversation is not one to have from a web page.

Why it takes four to five weeks for Wegovy to fully kick in too

The same seven-day half-life that governs clearance also governs onset. Because the medicine accumulates gradually, steady-state concentrations (where you have the full therapeutic amount in your blood) take four to five weeks of consistent weekly dosing to establish. This is why many people report modest effects in the first month and stronger appetite suppression from week five onwards. It is also one reason the titration schedule starts low: those early weeks at 0.25mg and 0.5mg allow your body to adjust to semaglutide while concentrations are still climbing, not yet at the ceiling.

For anyone curious about when results start to show, the detailed timeline of when Wegovy typically takes effect covers what to expect at each stage. The short version: early weeks are about tolerability; meaningful weight changes often become visible from month two or three, once steady-state is established and dose titration has progressed.

Tirzepatide works through a different dual mechanism, so its onset and clearance profile differs, if you are weighing up options, our treatment overview sets out the licensed choices currently available through nume.

What a missed dose does to your system, and to your results

Because steady-state takes weeks to build, a missed dose is not a clean reset. If you skip a week, semaglutide levels drop by roughly half before the next injection brings them back up. That dip can trigger a temporary return of appetite and, for some people, a brief rebound in nausea once dosing resumes, the body experiencing a small version of the start-up effect again. It is one reason clinical guidance recommends taking Wegovy on the same day each week and, where a dose is missed, following the instructions in the Patient Information Leaflet rather than doubling up.

Your prescriber is the right person to advise on what to do if you have missed one or more doses; specific guidance lives in the leaflet that arrives with your pen. That consistency matters for results too. The STEP 1 trial (published in the New England Journal of Medicine) reported an average weight loss of around 15% over 68 weeks at the 2.4mg maintenance dose, and that was in a population taking the medicine consistently every week. Gaps in dosing generally mean gaps in progress.

If you are wondering about cost as a factor in maintaining consistent supply, the cost of Wegovy through a UK private pharmacy page explains what current pricing looks like and what an all-inclusive service covers. Consistent supply, reviewed by a real clinician before every repeat order, is part of how we structure things at nume.

Surgery, stopping, and the questions that need a prescriber's answer

A longer half-life creates a practical complication for anyone facing surgery. Because semaglutide slows gastric emptying, residual food or liquid can sit in the stomach longer than usual, a risk factor for aspiration under anaesthetic even when you have fasted correctly. NHS England advises patients to tell their healthcare team, including the anaesthetist, that they are taking a GLP-1 medicine before any procedure. The clearance timeline above is relevant here: some teams ask patients to pause treatment several weeks ahead of an elective procedure, but the specific timing is a clinical call, not a general rule. Talk to your surgical team well in advance.

The same conversation applies to anyone planning to conceive. Wegovy is not recommended during pregnancy or breastfeeding, and your prescriber will advise on the appropriate gap between stopping and trying to conceive, taking the five-week clearance window into account alongside other factors. For the full picture of how long semaglutide lingers and what that means clinically, the semaglutide clearance guide goes deeper. If you are ready to explore whether Wegovy is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.